Pharma firms will face 15% tariffs in Trump E.U. trade deal

Taking stock of the drug industry, from the lab to the medicine chest

July 28, 2025 Check out STAT+

Sponsored By

By Ed Silverman Pharmalot Columnist, Senior Writer

FABRICE COFFRINI/AFP via Getty Images STAT+ | Pharma firms will face 15% tariffs in Trump's E.U. trade deal Taxes on pharmaceutical imports into the U.S. from the E.U. will be set at 15% as part of Trump's latest trade deal. By Daniel Payne STAT+ | Did a drug prevent this man's ALS? Jeff Vierstra was likely doomed by his DNA. A radical experiment gave him a chance to rewrite his fate — before ALS symptoms ever began. By Jason Mast STAT+ | FDA permits use of Sarepta Therapeutics' Duchenne therapy in younger patients after short-lived halt The agency said in a statement that the "voluntary hold" on the treatment for older patients remains in effect. By Adam Feuerstein Getty Images STAT+ | GSK pays $500M upfront for rights to series of Hengrui drugs The deal, centered on an experimental COPD drug, is the latest in which a pharma company has licensed medicines from a Chinese biotech. By Andrew Joseph Opinion: What I learned by going off SSRIs after nearly a decade STAT's Sarah Todd happened to go off escitalopram amid new public scrutiny of antidepressants. Here's what she found. By Sarah Todd

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Pharmalot? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2025, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser